Diasorin | DIA - Gross Profit On Sales

Stock Price
63.62
Daily Change
-0.12 -0.19%
Monthly
-9.40%
Yearly
-32.39%
Q1 Forecast
62.02

Diasorin reported EUR181.08M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Amplifon EUR 103.17M 44.14M Sep/2025
Avanos Medical USD 86M 0 Dec/2025
Brookdale Senior Living USD 210.85M 7.15M Sep/2025
Cencora USD 2.99B 31.87M Dec/2025
Diasorin EUR 181.08M 19.92M Sep/2025
Encompass Health USD 1.41B 786M Sep/2025
Enovis USD 349.42M 20.51M Dec/2025
GE HealthCare Technologies USD 2.26B 272M Dec/2025
OPKO Health USD 45M 1.89M Dec/2025
Pediatrix Medical Group 125.98M 366.89M Dec/2025
Veradigm USD 83.44M 3.95M Sep/2022
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025